Morgan Stanley Maintains Overweight on Corteva, Maintains $65 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Vincent Andrews maintains an Overweight rating on Corteva with a $65 price target.
September 24, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley analyst Vincent Andrews reaffirms an Overweight rating on Corteva, maintaining a $65 price target. This suggests confidence in Corteva's stock performance.
The reaffirmation of an Overweight rating and a $65 price target by a reputable analyst from Morgan Stanley indicates a positive outlook for Corteva's stock. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100